Clinical Trial Update: Randomized, Double-blind, Two Arms, Multicenter, Phase III Study of Berinert for Treatment of ACE Induced Angioedema [Phase 3]

View source ↗

Summary

Phase III randomized trial evaluating Berinert for acute ACE inhibitor–induced angioedema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ace-induced Angioedema

Drugs mentioned

• Berinert (C1 esterase inhibitor)

Snippet

Sponsor: Technical University of Munich | Conditions: Acute ACE-induced Angioedema | Phase 3 | Status: COMPLETED